Vivek Das/LinkedIn
Jul 31, 2026, 07:54
Vivek Das: From Inflammation to Integrated Precision Cardiovascular Care
Vivek Das, Lead Data Scientist at Novo Nordisk, shared a post on LinkedIn:
“A timely review from the European Society of Cardiology highlights an important direction for precision cardiovascular medicine.
While inflammation remains a key driver of coronary artery disease, meaningful progress will increasingly depend on integrating biomarkers, imaging, multi-omics, and clinical evidence to better understand residual risk and support more individualized care.
Equally important, translating these advances into practice will require robust evidence, careful validation, and thoughtful implementation.
An insightful read for anyone interested in the future of biomarkers and precision medicine.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C